每年專案
個人檔案
學歷
- 2007 亞利桑那大學藥事經濟博士
- 2003 伊利諾大學芝加哥分校藥學管理碩士
- 1999 臺灣大學藥學系學士
經歷
- 2020- 臺北醫學大學臨床藥學學科教授
- 2020- 臺北醫學大學臨床藥物基因體學暨蛋白質體學碩教授
- 2016- 臺北醫學大學藥學院藥事經濟研究中心主任
- 2015-2020 臺北醫學大學臨床藥物基因體學暨蛋白質體學碩副教授
- 2015-2020 臺北醫學大學臨床藥學學科副教授
- 2009-2014 新加坡大學助理教授
- 2007-2009 新加坡大學博士後研究員
研究興趣
- 藥事經濟暨效果研究
- 用藥安全
- 心理計量學
- 健康照護服務研究
指紋
查看啟用 Yu Ko 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
- 1 類似的個人檔案
過去五年中的合作和熱門研究領域
國家/地區層面的近期外部共同作業。按一下圓點深入探索詳細資料，或
專案
- 5 已完成
-
-
-
104年度科學及技術類委託研究計畫「健保已給付新藥副作用之風險評估_以口服抗凝血劑為例」計畫案
Chien, L.-N. (PI), Ko, Y. (CoI), Chien, S.-C. (CoI) & Chi, N.-F. (CoI)
12/23/15 → 12/22/16
研究計畫: A - 政府部門 › c - 衛生福利部暨其附屬機構
-
-
Sequential Treatment of Metastatic Colorectal Cancer in Taiwan: Real-World Evidence From Regorafenib and Trifluridine/Tipiracil Use
Chang, Y. W., Kuo, C. N., Chang, C. L., Hsu, J. & Ko, Y., 2025, (接受/付印) 於: Journal of Gastroenterology and Hepatology (Australia).研究成果: 雜誌貢獻 › 文章 › 同行評審
-
Cost-effectiveness analysis of granulocyte colony-stimulating factors for the prophylaxis of chemotherapy-induced febrile neutropenia in patients with breast cancer in Taiwan
Tseng, T. H., Chiang, S. C., Hsu, J. C. & Ko, Y., 6月 2024, 於: PLoS ONE. 19, 6 June, e0303294.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Cost-Utility Analysis of Bilateral Cochlear Implants for Children With Severe-to-Profound Sensorineural Hearing Loss in Taiwan
Lin, T. H., Lin, P. H., Fang, T. Y., Wu, C. C., Wang, P. C. & Ko, Y., 2024, (接受/付印) 於: Ear and Hearing. 46, 1, p. 139-149 11 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
-
Validation of Risk Models for Predicting Febrile Neutropenia Among Breast Cancer Patients Receiving Chemotherapy: A Real-World Study
Hsu, S. W., Chiang, S. C., Hsu, J. C. & Ko, Y., 2024, (接受/付印) 於: Clinical Therapeutics. 47, 2, p. e1-e4研究成果: 雜誌貢獻 › 文章 › 同行評審
-
Validation of the Chinese Version of the Speech, Spatial, and Qualities of Hearing Scale for Parents and Children
Fang, T. Y., Lin, P. H., Ko, Y., Wu, C. C., Wang, H., Liao, W. C. & Wang, P. C., 11月 1 2024, 於: Ear and Hearing. 45, 6, p. 1362-1368 7 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
資料集
-
Cost-utility analysis of second-line anti-diabetic therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin
Chien, C.-L. (Contributor), Chen, Y.-C. (Contributor), Malone, D. C. (Creator), Peng, Y.-L. (Contributor) & Ko, Y. (Creator), Taylor & Francis, 2020
DOI: 10.6084/m9.figshare.12871744.v1, https://tandf.figshare.com/articles/dataset/Cost-utility_analysis_of_second-line_anti-diabetic_therapy_in_patients_with_type_2_diabetes_mellitus_inadequately_controlled_on_metformin/12871744/1
資料集: Dataset
-
Patient preferences for diabetes-related complications in Taiwan
Ko, Y. (Creator), Cheng, S.-W. (Contributor), Lin, Y.-J. (Contributor) & Wang, C.-Y. (Contributor), Taylor & Francis, 2018
DOI: 10.6084/m9.figshare.6194663.v1, https://doi.org/10.6084%2Fm9.figshare.6194663.v1
資料集: Dataset
-
Talent cultivation in health technology assessment: an expert survey
Wu, Y.-S. (Creator), Chen, C. (Creator), Wang, L.-C. (Creator), Jian, L.-S. (Creator) & Ko, Y. (Creator), Figshare, 2022
DOI: 10.6084/m9.figshare.c.5883829.v1, https://springernature.figshare.com/collections/Talent_cultivation_in_health_technology_assessment_an_expert_survey/5883829/1
資料集: Dataset